LIGAND PHARMACEUTICALS INC ($LGND)
Filing Information
| Accession Number | 0002001011-26-000012 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 18, 2026 |
| Document Date | Feb 14, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
27,963
Total Value
$2,162,392.29
P&L
+inf% (+$3,409,938.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Feb 14, 2026 | Grant/Award | 7,390 | $0.00 | $0.00 | 35,965 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Feb 14, 2026 | Tax Withholding | 3,761 | $183.83 | $691,384.63 | 32,204 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Feb 14, 2026 | Grant/Award | 8,810 | $0.00 | $0.00 | 41,014 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Feb 14, 2026 | Tax Withholding | 4,483 | $183.83 | $824,109.89 | 36,531 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Feb 15, 2026 | Tax Withholding | 1,026 | $183.83 | $188,609.58 | 35,505 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Feb 15, 2026 | Tax Withholding | 1,223 | $183.83 | $224,824.09 | 34,282 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Feb 15, 2026 | Tax Withholding | 1,270 | $183.83 | $233,464.10 | 33,012 | Direct | โ | View Details |